LMR Partners’s MiMedx Group MDXG Stock Holding History

LMR Partners’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-58,621	Closed	-$604K	–	1246
2021 Q1	$604K	Buy	+58,621	New	+$566K	0.02%	592

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

LMR Partners's MDXG Position: Q2 2021 in Review

LMR Partners sold out of MiMedx Group (MDXG) in Q2 2021, closing a stake of 58,621 shares — an estimated $604K sold.

LMR Partners first reported a position in MDXG in Q1 2021 and held it in 1 quarter. The position peaked at $604K in Q1 2021. 138 funds tracked by Wall St. Rank hold MDXG as of Q2 2021.

LMR Partners reported no remaining MiMedx Group position as of Q2 2021 after selling out during the quarter.
LMR Partners sold 58,621 MiMedx Group shares in Q2 2021, an estimated $604K.
LMR Partners first reported a position in MiMedx Group in Q1 2021 and held it in 1 quarter.
LMR Partners's MiMedx Group position peaked at $604K in Q1 2021.
138 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2021.

Based on LMR Partners's 13F filing for Q2 2021, filed 16 Aug 2021.